SA and Zambia’s HIV shot dilemma: Demand versus supply
South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection.
Despite high demand and promising early results, limited supplies mean clinics often run out of stock, creating a complex balancing act between generating awareness and ensuring equitable access.
Read the full article
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on mg.co.za — the content belongs to Mail & Guardian.
